Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
31.69
-0.35 (-1.09%)
Apr 30, 2026, 3:00 PM CST
-26.01%
Market Cap 4.91B
Revenue (ttm) 3.35B
Net Income (ttm) 337.40M
Shares Out 153.40M
EPS (ttm) 2.20
PE Ratio 14.57
Forward PE n/a
Dividend 0.90 (2.84%)
Ex-Dividend Date Apr 28, 2026
Volume 1,026,200
Average Volume 2,500,548
Open 32.20
Previous Close 32.04
Day's Range 31.61 - 32.20
52-Week Range 31.03 - 43.72
Beta 0.35
RSI 37.87
Earnings Date Mar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China. [Read more]

Sector Healthcare
Founded 1637
Employees 2,257
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.

Financial Statements

News

There is no news available yet.